Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
International Congress of Parkinson's Disease and Movement Disorders (MDS) 2021
September 17 - 22, 2021; Virtual
September 17 - 22, 2021Virtual
MDS 2021Safer Way to Use Botox to Treat Challenging Dystonia Type?When treating oromandibular dystonia with botulinum toxin injection to the lateral pterygoid muscle, an intraoral approach is the safest way to avoid injury to the maxillary artery, new research suggests.
Medscape Medical News, October 5, 2021
MDS 2021Apple Devices Identify Early Parkinson's DiseaseSmartwatch motion sensors, cognitive tasks, and motor exams can differentiate between patients with early, untreated Parkinson's disease and healthy controls, new research shows.
Gene Variants May Affect PD Risk After Pesticide ExposureVariants of genes linked to Parkinson's disease may increase the risk of developing the disease as well as cognitive impairment
when people are exposed to pesticides, an epidemiologic study suggests.
Medscape Medical News, Oct 20, 2020
Prodrugs Infusion Beats Oral PD Therapy for Motor SymptomsA continuous subcutaneous infusion of foslevodopa/foscarbidopa controlled the motor symptoms of advanced Parkinson's disease
better compared with oral levodopa/carbidopa, a study shows.
Medscape Medical News, Oct 12, 2020
Flecainide Plus Modafinil Relieves Sleepiness in Parkinson'sA phase 2 study shows low-dose flecainide added to modafinil relieved excessive day-time sleepiness for some patients with
Parkinson's disease without affecting cognition or motor symptoms.
